Previous close | 164.47 |
Open | 164.38 |
Bid | 136.00 |
Ask | 144.90 |
Strike | 560.00 |
Expiry date | 2026-01-16 |
Day's range | 164.38 - 164.47 |
Contract range | N/A |
Volume | |
Open interest | 43 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning